Isabelle Dubuc
2705 Boul. Laurier, PQ
Laval, QC G1V4G2, Canada
Laval, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Megakaryocytes Internalize and Are Activated by Immune Complexes.
Journal: Circulation research
Published: June 16, 2026
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 03, 2025
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 18, 2025
A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method.
Journal: Frontiers in genetics
Published: October 24, 2024
Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged mice.
Journal: Immunity & ageing : I & A
Published: October 04, 2024
Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19.
Journal: Stem cell reviews and reports
Published: September 24, 2024
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow.
Journal: Blood advances
Published: December 07, 2023
Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.
Journal: Frontiers in pharmacology
Published: September 27, 2023
SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB.
Journal: Viruses
Published: December 20, 2022
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 20, 2022
Last Updated: 09/26/2026